A detailed history of Benin Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Benin Management Corp holds 1,011 shares of AMGN stock, worth $314,299. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,011
Previous 1,002 0.9%
Holding current value
$314,299
Previous $288,000 0.35%
% of portfolio
0.09%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$268.87 - $324.56 $2,419 - $2,921
9 Added 0.9%
1,011 $287,000
Q4 2023

Jan 25, 2024

BUY
$255.7 - $288.46 $1,789 - $2,019
7 Added 0.7%
1,002 $288,000
Q3 2023

Oct 19, 2023

BUY
$218.65 - $271.46 $217,556 - $270,102
995 New
995 $267,000
Q1 2023

Apr 25, 2023

BUY
$225.79 - $275.2 $191,921 - $233,920
850 New
850 $205,000
Q2 2022

Aug 03, 2022

SELL
$230.71 - $256.74 $657,754 - $731,965
-2,851 Closed
0 $0
Q1 2022

Apr 21, 2022

SELL
$219.27 - $242.57 $21,927 - $24,257
-100 Reduced 3.39%
2,851 $689,000
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $233,087 - $266,747
1,172 Added 65.88%
2,951 $664,000
Q3 2021

Oct 25, 2021

SELL
$212.27 - $248.7 $212 - $248
-1 Reduced 0.06%
1,779 $378,000
Q2 2021

Jul 21, 2021

SELL
$233.58 - $259.14 $2,335 - $2,591
-10 Reduced 0.56%
1,780 $434,000
Q1 2021

Apr 27, 2021

SELL
$221.91 - $258.6 $22,191 - $25,860
-100 Reduced 5.29%
1,790 $445,000
Q3 2020

Oct 22, 2020

SELL
$234.65 - $260.95 $5,866 - $6,523
-25 Reduced 1.31%
1,890 $480,000
Q2 2020

Jul 22, 2020

SELL
$197.81 - $242.74 $9,890 - $12,137
-50 Reduced 2.54%
1,915 $452,000
Q1 2020

Apr 20, 2020

SELL
$182.24 - $241.7 $27,336 - $36,255
-150 Reduced 7.09%
1,965 $398,000
Q4 2019

Jan 23, 2020

SELL
$189.21 - $243.2 $3,784 - $4,864
-20 Reduced 0.94%
2,115 $510,000
Q3 2019

Oct 22, 2019

SELL
$174.11 - $208.62 $43,527 - $52,155
-250 Reduced 10.48%
2,135 $413,000
Q4 2018

Jan 22, 2019

SELL
$178.4 - $208.25 $22,300 - $26,031
-125 Reduced 4.98%
2,385 $464,000
Q3 2018

Oct 17, 2018

SELL
$185.29 - $208.89 $3,705 - $4,177
-20 Reduced 0.79%
2,510 $520,000
Q1 2018

Apr 24, 2018

SELL
$169.43 - $198.0 $237,202 - $277,200
-1,400 Reduced 35.62%
2,530 $431,000
Q4 2017

Jan 18, 2018

SELL
$168.79 - $188.59 $14,347 - $16,030
-85 Reduced 2.12%
3,930 $683,000
Q3 2017

Oct 13, 2017

BUY
$167.29 - $191.0 $671,669 - $766,865
4,015
4,015 $749,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Benin Management Corp Portfolio

Follow Benin Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benin Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Benin Management Corp with notifications on news.